MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that causes painful nodules, abscesses, and draining tunnels under the skin. It most often appears in the armpits, groin, buttocks, and inner thighs. If you live with HS, you know flare-ups can disrupt sleep, work, relationships,
A shoulder tear can take over your life. Constant pain, limited movement, and the prospect of surgery leave many patients searching for non-surgical alternatives. If you’re new to this field, it helps to understand how regenerative medicine differs from other forms of medicine before exploring
Why the nose? The brain is one of the hardest organs in the body to reach with medicine. A protective layer called the blood-brain barrier keeps most of what travels in the bloodstream out of the central nervous system. That barrier is good at its
As regenerative medicine gains attention worldwide, one question comes up more than any other among prospective patients: can stem cell therapy increase the risk of cancer? Clinics now market mesenchymal stem cells (MSCs) for conditions ranging from autoimmune disease and joint degeneration to recovery after
Soft tissue injuries—including rotator cuff tears, hamstring strains, ligament sprains, and chronic elbow tendinitis—are among the most common injuries athletes face. For decades, standard medical protocols focused heavily on immediate symptom management using non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroid injections. While these options can temporarily
Ischemic heart disease and acute myocardial infarction (heart attack) remain leading causes of morbidity and mortality worldwide. When a blockage restricts blood supply to the myocardium, oxygen deprivation causes cardiomyocytes (heart muscle cells) to die, leaving behind non-contractile scar tissue. Because the human heart has
Amyotrophic lateral sclerosis (ALS) is a progressive disease that affects the nerve cells controlling voluntary muscle movement. As motor neurons die, patients gradually lose the ability to walk, speak, swallow, and eventually breathe. Because ALS currently has no cure and few effective drug treatments, many
Exosomes, which are a type of extracellular vesicle, have become extremely popular in the United States over the past few years. There are several reasons for this, which are explained below. The top exosome distributor and supplier in the USA is ReBella Suppliers, which offers
Parkinson’s disease is a progressive neurodegenerative disorder marked by the gradual loss of dopaminergic neurons in the substantia nigra region of the brain. As dopamine levels drop, patients experience tremors, rigidity, bradykinesia (slowed movement), and postural instability. While standard pharmaceutical treatments (such as levodopa) help
Chronic exposure to cigarette smoke remains the leading cause of progressive lung conditions such as Chronic Obstructive Pulmonary Disease (COPD), pulmonary emphysema, and lung tissue fibrosis. Smoke inhalation introduces thousands of toxic chemical compounds into the respiratory tract, triggering widespread oxidative stress, tissue degradation, and
